These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 8363996)
21. Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting. Anderson H; Thatcher N; Howell A; Logan K; Sage T; de Bruijn KM Eur J Cancer; 1994; 30A(5):610-5. PubMed ID: 8080674 [TBL] [Abstract][Full Text] [Related]
22. Compassionate use of tropisetron in patients at high risk of severe emesis. Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M Ann Oncol; 1993; 4 Suppl 3():43-5. PubMed ID: 8364000 [TBL] [Abstract][Full Text] [Related]
23. Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205-930. Gamse R Cancer Treat Rev; 1990 Sep; 17(2-3):301-5. PubMed ID: 2272046 [TBL] [Abstract][Full Text] [Related]
24. Tropisetron and the 5-HT3 Antiemetics in Perspective. Proceedings of an international symposium. Vienna, Austria, October 2, 1992. Ann Oncol; 1993; 4 Suppl 3():1-47. PubMed ID: 8103353 [No Abstract] [Full Text] [Related]
25. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412 [TBL] [Abstract][Full Text] [Related]
26. The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation. Barbounis V; Koumakis G; Hatzichristou H; Vassilomanolakis M; Tsoussis S; Efremidis A Support Care Cancer; 1999 Mar; 7(2):79-83. PubMed ID: 10089087 [TBL] [Abstract][Full Text] [Related]
27. Prevention of emesis by ICS 205-930 in children receiving cytotoxic chemotherapy. Hachimi-Idrissi S; De Schepper J; Maurus R; Otten J Eur J Cancer; 1993; 29A(6):854-6. PubMed ID: 8484976 [TBL] [Abstract][Full Text] [Related]
28. Optimal control of acute cisplatin-induced emesis. Verweij J; de Wit R; de Mulder PH Oncology; 1996 Jun; 53 Suppl 1():56-64. PubMed ID: 8692553 [TBL] [Abstract][Full Text] [Related]
29. Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. Bregni M; Siena S; Di Nicola M; Bonadonna G; Gianni AM Eur J Cancer; 1991; 27(5):561-5. PubMed ID: 1828962 [TBL] [Abstract][Full Text] [Related]
30. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis. Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907 [TBL] [Abstract][Full Text] [Related]
31. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Natale JJ Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912 [TBL] [Abstract][Full Text] [Related]
32. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma. Slabý J; Trnený M; Procházka B; Klener P Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251 [TBL] [Abstract][Full Text] [Related]
33. Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities. Del Favero A; Roila F; Tonato M Drug Saf; 1993 Dec; 9(6):410-28. PubMed ID: 7510495 [TBL] [Abstract][Full Text] [Related]
34. [The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs]. Wang J; Yang L; Cui C Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):251-3. PubMed ID: 11783100 [TBL] [Abstract][Full Text] [Related]
35. Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy. Bruntsch U; Drechsler S; Hiller E; Eiermann W; Tulusan AH; Bühner M; Hartenstein R; Koenig HJ; Gallmeier WM Drugs; 1992; 43 Suppl 3():23-6. PubMed ID: 1380429 [TBL] [Abstract][Full Text] [Related]
36. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial. Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488 [TBL] [Abstract][Full Text] [Related]
37. [Research on antiemetics: an Italian model of success]. Roila F Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377 [TBL] [Abstract][Full Text] [Related]
38. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin. Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236 [TBL] [Abstract][Full Text] [Related]
39. [Prophylaxis of chemotherapy-induced vomiting and nausea]. Tóth J; Szántó J Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468 [TBL] [Abstract][Full Text] [Related]
40. Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis. Garbe C; Drechsler S; Fiedler H; Tilgen W; Landthaler M; Schroeder K; Kuehne KH; Faerber L Semin Oncol; 1994 Oct; 21(5 Suppl 9):12-6. PubMed ID: 9113121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]